Austin Health

Title
Mind bomb 2 limits inflammatory dermatitis in Sharpin mutant mice independently of cell death.
Publication Date
2024-01
Author(s)
Simpson, Daniel S
Anderton, Holly
Yousef, Jumana
Vaibhav, Vineet
Cobbold, Simon A
Bandala-Sanchez, Esther
Kueh, Andrew J
Dagley, Laura F
Herold, Marco J
Silke, John
Vince, James E
Feltham, Rebecca
Subject
Sharpin
TNF
cpdm
dermatitis
mind bomb 2
Type of document
Journal Article
OrcId
0000-0002-6248-427X
0000-0003-3913-9686
0000-0002-2364-6299
#PLACEHOLDER_PARENT_METADATA_VALUE#
0000-0002-9927-8998
0000-0003-3875-8872
#PLACEHOLDER_PARENT_METADATA_VALUE#
0000-0003-4171-3712
0000-0001-7539-7581
0000-0002-7611-5774
0000-0001-7166-2798
0000-0001-8376-6869
DOI
10.1093/pnasnexus/pgad438
Abstract
Skin inflammation is a complex process implicated in various dermatological disorders. The chronic proliferative dermatitis (cpd) phenotype driven by the cpd mutation (cpdm) in the Sharpin gene is characterized by dermal inflammation and epidermal abnormalities. Tumour necrosis factor (TNF) and caspase-8-driven cell death causes the pathogenesis of Sharpincpdm mice; however, the role of mind bomb 2 (MIB2), a pro-survival E3 ubiquitin ligase involved in TNF signaling, in skin inflammation remains unknown. Here, we demonstrate that MIB2 antagonizes inflammatory dermatitis in the context of the cpd mutation. Surprisingly, the role of MIB2 in limiting skin inflammation is independent of its known pro-survival function and E3 ligase activity. Instead, MIB2 enhances the production of wound-healing molecules, granulocyte colony-stimulating factor, and Eotaxin, within the skin. This discovery advances our comprehension of inflammatory cytokines and chemokines associated with cpdm pathogenesis and highlights the significance of MIB2 in inflammatory skin disease that is independent of its ability to regulate TNF-induced cell death.
Link
Citation
PNAS Nexus 2024-01; 3(1)
Jornal Title
PNAS Nexus
ISSN
2752-6542

Files:

NameSizeformatDescriptionLink